<?xml version="1.0" encoding="UTF-8"?>
<!--
  Copyright SemanticBits, Northwestern University and Akaza Research
  
  Distributed under the OSI-approved BSD 3-Clause License.
  See http://ncip.github.com/caaers/LICENSE.txt for details.
-->
<AE_REPORT>
	<REPORT_TYPE>$RT</REPORT_TYPE>
	<!--TN,AN-->

	<REPORTER_INFORMATION FIRST_NAME="Roberto" LAST_NAME="Pili" PHONE="(000)000-0000" EMAIL="default@abc.com" FAX="(000)000-0000"/>
	<PHYSICIAN_INFORMATION FIRST_NAME="Roberto" LAST_NAME="Pili" PHONE="(000)000-0000" EMAIL="default@abc.com"/>
	<SUBMITTER_INFORMATION FIRST_NAME="Roberto" LAST_NAME="Pili" PHONE="(000)000-0000" EMAIL="default@abc.com" FAX="(000)000-0000"/>
	<INSTITUTION_INFORMATION CTEP_ID="MD017">
		<INSTITUTION_NAME>Johns Hopkins University</INSTITUTION_NAME>
	</INSTITUTION_INFORMATION>
	<PROTOCOL_INFORMATION NCI_PROTOCOL_NUMBER="5876"/>
	<TREATMENT_ASSIGNMENT_INFORMATION>
		<TREATMENT_ASSIGNMENT_CODE>A</TREATMENT_ASSIGNMENT_CODE>
	</TREATMENT_ASSIGNMENT_INFORMATION>
	<COURSE_INFORMATION>
		<START_DATE_OF_FIRST_COURSE>2000-06-01</START_DATE_OF_FIRST_COURSE>
		<START_DATE_OF_AE_COURSE>2008-01-01</START_DATE_OF_AE_COURSE>
		<COURSE_NUMBER_OF_AE>1</COURSE_NUMBER_OF_AE>
		<TOTAL_NUMBER_OF_COURSES>4</TOTAL_NUMBER_OF_COURSES>
		<INV_AGENT_ADMIN>Yes</INV_AGENT_ADMIN>
	</COURSE_INFORMATION>
	<DESCRIPTION_OF_EVENT>
		<EVENT_DESCRIPTION>test</EVENT_DESCRIPTION>
		<PRESENT_STATUS>Intervention for AE Continues</PRESENT_STATUS>
		<RETREATED>No</RETREATED>
		<REMOVED_FROM_PROTOCOL_TRT>No</REMOVED_FROM_PROTOCOL_TRT>
	</DESCRIPTION_OF_EVENT>
	<PATIENT_INFORMATION PATIENT_ID="2345">
		<BIRTH_DATE>1960-01</BIRTH_DATE>
		<RACE>Black or African American</RACE>
		<ETHNICITY>Hispanic or Latino</ETHNICITY>
		<GENDER>Male</GENDER>
		<HEIGHT>1</HEIGHT>
		<WEIGHT>1</WEIGHT>
		<BASELINE_PERFORMANCE_STATUS>1</BASELINE_PERFORMANCE_STATUS>
		<DISEASE_NAME>Ovarian epithelial cancer</DISEASE_NAME>
		<PRIMARY_ANATOMIC_SITE>Other</PRIMARY_ANATOMIC_SITE>
		<OTHER_PRIMARY_SITE_OF_DISEASE>Adrenal Gland</OTHER_PRIMARY_SITE_OF_DISEASE>
	</PATIENT_INFORMATION>
	<PRIOR_THERAPY>
		<THERAPY_NAME>Antisense</THERAPY_NAME>
	</PRIOR_THERAPY>
	<PROTOCOL_AGENT AGENT_NAME="Alvocidib (flavopiridol)" NSC_NUMBER="649890">
		<TOTAL_DOSE_ADMINISTERED>1</TOTAL_DOSE_ADMINISTERED>
		<LAST_ADMINISTERED_DATE>2009-06-11</LAST_ADMINISTERED_DATE>
		<DOSE_UOM>MeV</DOSE_UOM>
		<AGENT_DELAYED>No</AGENT_DELAYED>
	</PROTOCOL_AGENT>
	<ADVERSE_EVENT_CTC GRADE="4">
		<IS_PRIMARY_AE>Yes</IS_PRIMARY_AE>
		<CATEGORY>PULMONARY/UPPER RESPIRATORY</CATEGORY>
		<AE_TERM>Atelectasis</AE_TERM>
		<AE_START_DATE>2009-06-03</AE_START_DATE>
		<HOSPITALIZATION>Yes</HOSPITALIZATION>
		<ATTRIBUTION_FOR_AE>
			<CAUSE_NAME>Alvocidib (flavopiridol)</CAUSE_NAME>
			<TYPE_OF_CAUSE>AGENT</TYPE_OF_CAUSE>
			<ATTRIBUTION>Possible</ATTRIBUTION>
		</ATTRIBUTION_FOR_AE>
		<ATTRIBUTION_FOR_AE>
			<CAUSE_NAME>Ovarian epithelial cancer</CAUSE_NAME>
			<TYPE_OF_CAUSE>DISEASE</TYPE_OF_CAUSE>
			<ATTRIBUTION>Possible</ATTRIBUTION>
		</ATTRIBUTION_FOR_AE>
	</ADVERSE_EVENT_CTC>
</AE_REPORT>
